Aspirin-triggered lipoxin A4 stimulates alternative activation of microglia and reduces alzheimer disease-like pathology in mice

American Journal of Pathology

Volumn 182, Issue 5, 2013, Pages 1780-1789

  Medeiros, Rodrigo ^a,b   Kitazawa, Masashi ^a,b   Passos, Giselle F ^a   Baglietto Vargas, David ^a,b   Cheng, David ^a,b   Cribbs, David H ^a,b   Laferla, Frank M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMYLOID BETA PROTEIN; ARGINASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; LIPOXIN A; TRANSFORMING GROWTH FACTOR BETA;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; MALE; MICROGLIA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ASPIRIN; ASTROCYTES; BRAIN; COGNITION; LIPOXINS; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; NEUROPROTECTIVE AGENTS; NF-KAPPA B; PHENOTYPE; PROTEIN PROCESSING, POST-TRANSLATIONAL; SYNAPSES;

EID: 84876536265     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.01.051     Document Type: Article

References (58)

1. H.W. Querfurth, and F.M. LaFerla Alzheimer's disease N Engl J Med 362 2010 329 344
2. H. Akiyama, S. Barger, S. Barnum, B. Bradt, J. Bauer, and G.M. Cole Inflammation and Alzheimer's disease Neurobiol Aging 21 2000 383 421
3. M.B. Graeber Changing face of microglia Science 330 2010 783 788
4. K.M. Lucin, and T. Wyss-Coray Immune activation in brain aging and neurodegeneration: too much or too little? Neuron 64 2009 110 122
5. H. Neumann, M.R. Kotter, and R.J. Franklin Debris clearance by microglia: an essential link between degeneration and regeneration Brain 132 2009 288 295
6. O. Pascual, S. Ben Achour, P. Rostaing, A. Triller, and A. Bessis Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission Proc Natl Acad Sci U S A 109 2012 E197 E205
7. M.E. Tremblay, B. Stevens, A. Sierra, H. Wake, A. Bessis, and A. Nimmerjahn The role of microglia in the healthy brain J Neurosci 31 2011 16064 16069
8. E. Czirr, and T. Wyss-Coray The immunology of neurodegeneration J Clin Invest 122 2012 1156 1163
9. M. Prinz, J. Priller, S.S. Sisodia, and R.M. Ransohoff Heterogeneity of CNS myeloid cells and their roles in neurodegeneration Nat Neurosci 14 2011 1227 1235
10. J. Koenigsknecht-Talboo, and G.E. Landreth Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines J Neurosci 25 2005 8240 8249
11. S. Mandrekar-Colucci, and G.E. Landreth Microglia and inflammation in Alzheimer's disease CNS Neurol Disord Drug Targets 9 2010 156 167
12. R. Medeiros, G.B. Rodrigues, C.P. Figueiredo, E.B. Rodrigues, A. Grumman Jr., O. Menezes-de-Lima Jr., G.F. Passos, and J.B. Calixto Molecular mechanisms of topical anti-inflammatory effects of lipoxin A(4) in endotoxin-induced uveitis Mol Pharmacol 74 2008 154 161
13. M. Sobrado, M.P. Pereira, I. Ballesteros, O. Hurtado, D. Fernandez-Lopez, J.M. Pradillo, J.R. Caso, J. Vivancos, F. Nombela, J. Serena, I. Lizasoain, and M.A. Moro Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke J Neurosci 29 2009 3875 3884
14. O. Haworth, M. Cernadas, R. Yang, C.N. Serhan, and B.D. Levy Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation Nat Immunol 9 2008 873 879
15. C.I. Svensson, M. Zattoni, and C.N. Serhan Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing J Exp Med 204 2007 245 252
16. C.N. Serhan Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution Prostaglandins Leukot Essent Fatty Acids 73 2005 141 162
17. R.D. Ye, F. Boulay, J.M. Wang, C. Dahlgren, C. Gerard, M. Parmentier, C.N. Serhan, and P.M. Murphy International Union of Basic and Clinical Pharmacology, LXXIII: nomenclature for the formyl peptide receptor (FPR) family Pharmacol Rev 61 2009 119 161
18. C.N. Serhan Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways Annu Rev Immunol 25 2007 101 137
19. Y. Wu, X.H. Ye, P.P. Guo, S.P. Xu, J. Wang, S.Y. Yuan, S.L. Yao, and Y. Shang Neuroprotective effect of lipoxin A4 methyl ester in a rat model of permanent focal cerebral ischemia J Mol Neurosci 42 2010 226 234
20. J. Wu, A. Wang, Z. Min, Y. Xiong, Q. Yan, J. Zhang, J. Xu, and S. Zhang Lipoxin A4 inhibits the production of proinflammatory cytokines induced by beta-amyloid in vitro and in vivo Biochem Biophys Res Commun 408 2011 382 387
21. K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice Science 274 1996 99 102
22. R. Medeiros, M. Kitazawa, A. Caccamo, D. Baglietto-Vargas, T. Estrada-Hernandez, D.H. Cribbs, A. Fisher, and F.M. LaFerla Loss of muscarinic M1 receptor exacerbates Alzheimer's disease-like pathology and cognitive decline Am J Pathol 179 2011 980 991
23. M. Rossner, and K.M. Yamada What's in a picture? the temptation of image manipulation J Cell Biol 166 2004 11 15
24. T. Town, Y. Laouar, C. Pittenger, T. Mori, C.A. Szekely, J. Tan, R.S. Duman, and R.A. Flavell Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology Nat Med 14 2008 681 687
25. A.E. Budson, and B.H. Price Memory dysfunction N Engl J Med 352 2005 692 699
26. R.G. Morris, P. Garrud, J.N. Rawlins, and J. O'Keefe Place navigation impaired in rats with hippocampal lesions Nature 297 1982 681 683
27. G.R. Barker, F. Bird, V. Alexander, and E.C. Warburton Recognition memory for objects, place, and temporal order: a disconnection analysis of the role of the medial prefrontal cortex and perirhinal cortex J Neurosci 27 2007 2948 2957
28. R.G. Phillips, and J.E. LeDoux Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning Behav Neurosci 106 1992 274 285
29. Q. Jiang, C.Y. Lee, S. Mandrekar, B. Wilkinson, P. Cramer, N. Zelcer, K. Mann, B. Lamb, T.M. Willson, J.L. Collins, J.C. Richardson, J.D. Smith, T.A. Comery, D. Riddell, D.M. Holtzman, P. Tontonoz, and G.E. Landreth ApoE promotes the proteolytic degradation of Abeta Neuron 58 2008 681 693
30. S.E. Wahrle, H. Jiang, M. Parsadanian, J. Kim, A. Li, A. Knoten, S. Jain, V. Hirsch-Reinshagen, C.L. Wellington, K.R. Bales, S.M. Paul, and D.M. Holtzman Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease J Clin Invest 118 2008 671 682
31. Q. Liu, C.V. Zerbinatti, J. Zhang, H.S. Hoe, B. Wang, S.L. Cole, J. Herz, L. Muglia, and G. Bu Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1 Neuron 56 2007 66 78
32. K. Vekrellis, Z. Ye, W.Q. Qiu, D. Walsh, D. Hartley, V. Chesneau, M.R. Rosner, and D.J. Selkoe Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme J Neurosci 20 2000 1657 1665
33. N. Iwata, S. Tsubuki, Y. Takaki, K. Watanabe, M. Sekiguchi, E. Hosoki, M. Kawashima-Morishima, H.J. Lee, E. Hama, Y. Sekine-Aizawa, and T.C. Saido Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition Nat Med 6 2000 143 150
34. P. Marambaud, H. Zhao, and P. Davies Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides J Biol Chem 280 2005 37377 37382
35. T. Wyss-Coray, C. Lin, F. Yan, G.Q. Yu, M. Rohde, L. McConlogue, E. Masliah, and L. Mucke TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice Nat Med 7 2001 612 618
36. J. El Khoury, M. Toft, S.E. Hickman, T.K. Means, K. Terada, C. Geula, and A.D. Luster Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease Nat Med 13 2007 432 438
37. P. Maderna, D.C. Cottell, T. Toivonen, N. Dufton, J. Dalli, M. Perretti, and C. Godson FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis FASEB J 24 2010 4240 4249
38. K. Reville, J.K. Crean, S. Vivers, I. Dransfield, and C. Godson Lipoxin A4 redistributes myosin IIA and Cdc42 in macrophages: implications for phagocytosis of apoptotic leukocytes J Immunol 176 2006 1878 1888
39. J.F. Maddox, and C.N. Serhan Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction J Exp Med 183 1996 137 146
40. M. Romano, J.F. Maddox, and C.N. Serhan Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization J Immunol 157 1996 2149 2154
41. S. Gordon, and F.O. Martinez Alternative activation of macrophages: mechanism and functions Immunity 32 2010 593 604
42. S. Gordon, and P.R. Taylor Monocyte and macrophage heterogeneity Nat Rev 5 2005 953 964
43. F.O. Martinez, S. Gordon, M. Locati, and A. Mantovani Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression J Immunol 177 2006 7303 7311
44. C.K. Glass, and K. Saijo Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells Nat Rev Immunol 10 2010 365 376
45. K. Saijo, A. Crotti, and C.K. Glass Nuclear receptors, inflammation, and neurodegenerative diseases Adv Immunol 106 2010 21 59
46. G. Bonizzi, and M. Karin The two NF-kappaB activation pathways and their role in innate and adaptive immunity Trends Immunol 25 2004 280 288
47. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
48. R. Solana, G. Pawelec, and R. Tarazona Aging and innate immunity Immunity 24 2006 491 494
49. S. Amor, F. Puentes, D. Baker, and P. van der Valk Inflammation in neurodegenerative diseases Immunology 129 2010 154 169
50. F. Licastro, G. Candore, D. Lio, E. Porcellini, G. Colonna-Romano, C. Franceschi, and C. Caruso Innate immunity and inflammation in ageing: a key for understanding age-related diseases Immun Ageing 2 2005 8
51. T. Wyss-Coray, and L. Mucke Inflammation in neurodegenerative disease: a double-edged sword Neuron 35 2002 419 432
52. C.N. Serhan, N. Chiang, and T.E. Van Dyke Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators Nat Rev Immunol 8 2008 349 361
53. G.W. Kreutzberg Microglia: a sensor for pathological events in the CNS Trends Neurosci 19 1996 312 318
54. R.M. Ransohoff, and V.H. Perry Microglial physiology: unique stimuli, specialized responses Annu Rev Immunol 27 2009 119 145
55. U.K. Hanisch, and H. Kettenmann Microglia: active sensor and versatile effector cells in the normal and pathologic brain Nat Neurosci 10 2007 1387 1394
56. C.A. Colton, and D.M. Wilcock Assessing activation states in microglia CNS Neurol Disord Drug Targets 9 2010 174 191
57. S. Jimenez, D. Baglietto-Vargas, C. Caballero, I. Moreno-Gonzalez, M. Torres, R. Sanchez-Varo, D. Ruano, M. Vizuete, A. Gutierrez, and J. Vitorica Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer's disease: age-dependent switch in the microglial phenotype from alternative to classic J Neurosci 28 2008 11650 11661
58. I. Tesseur, K. Zou, L. Esposito, F. Bard, E. Berber, J.V. Can, A.H. Lin, L. Crews, P. Tremblay, P. Mathews, L. Mucke, E. Masliah, and T. Wyss-Coray Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology J Clin Invest 116 2006 3060 3069